[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

UY35394A - Procesos para la preparación de un agente inductor de la apoptosis - Google Patents

Procesos para la preparación de un agente inductor de la apoptosis

Info

Publication number
UY35394A
UY35394A UY0001035394A UY35394A UY35394A UY 35394 A UY35394 A UY 35394A UY 0001035394 A UY0001035394 A UY 0001035394A UY 35394 A UY35394 A UY 35394A UY 35394 A UY35394 A UY 35394A
Authority
UY
Uruguay
Prior art keywords
preparation
processes
inductive agent
apoptosis
apoptosis inductive
Prior art date
Application number
UY0001035394A
Other languages
English (en)
Inventor
Barkalow Jufang
Jean-Christophe Califano
Vicent S Chan
Alan C Christesen
Timothy A Grieme
Yi-Yin-Ku
Mathew M Mulhern
Yu-Ming M Pu
Original Assignee
Abbvie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Inc filed Critical Abbvie Inc
Priority to UY0001039847A priority Critical patent/UY39847A/es
Priority to UY0001039848A priority patent/UY39848A/es
Publication of UY35394A publication Critical patent/UY35394A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/455Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation with carboxylic acids or their derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/38Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings
    • C07C47/457Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Health & Medical Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un proceso para la preparación de un agente inductor de la apoptosis, y sustancias químicas interme diarias del mismo.También, novedosas sustancias q uímicas intermediarias relacionadas con dicho proceso.
UY0001035394A 2013-03-13 2014-03-12 Procesos para la preparación de un agente inductor de la apoptosis UY35394A (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
UY0001039847A UY39847A (es) 2013-03-13 2014-03-12 Procesos para la preparación de un agente inductor de la apoptosis
UY0001039848A UY39848A (es) 2013-03-13 2014-03-12 Procesos para la preparación de un agente inductor de la apoptosis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361780621P 2013-03-13 2013-03-13
US201461947850P 2014-03-04 2014-03-04

Publications (1)

Publication Number Publication Date
UY35394A true UY35394A (es) 2014-09-30

Family

ID=50439506

Family Applications (3)

Application Number Title Priority Date Filing Date
UY0001039847A UY39847A (es) 2013-03-13 2014-03-12 Procesos para la preparación de un agente inductor de la apoptosis
UY0001035394A UY35394A (es) 2013-03-13 2014-03-12 Procesos para la preparación de un agente inductor de la apoptosis
UY0001039848A UY39848A (es) 2013-03-13 2014-03-12 Procesos para la preparación de un agente inductor de la apoptosis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UY0001039847A UY39847A (es) 2013-03-13 2014-03-12 Procesos para la preparación de un agente inductor de la apoptosis

Family Applications After (1)

Application Number Title Priority Date Filing Date
UY0001039848A UY39848A (es) 2013-03-13 2014-03-12 Procesos para la preparación de un agente inductor de la apoptosis

Country Status (31)

Country Link
EP (5) EP3569588A1 (es)
JP (2) JP6357220B2 (es)
KR (1) KR102230339B1 (es)
CN (3) CN111960944A (es)
AU (2) AU2014248742B2 (es)
BR (3) BR112015021540B1 (es)
CA (3) CA3090936C (es)
CL (1) CL2015002548A1 (es)
CR (1) CR20150495A (es)
CY (1) CY1120576T1 (es)
DK (1) DK2970263T3 (es)
ES (1) ES2683378T3 (es)
HK (2) HK1216644A1 (es)
HR (1) HRP20181273T1 (es)
HU (1) HUE039046T2 (es)
IL (2) IL240779B (es)
LT (1) LT2970263T (es)
MX (1) MX365343B (es)
MY (1) MY192466A (es)
PE (2) PE20191685A1 (es)
PH (2) PH12015501960A1 (es)
PL (1) PL2970263T3 (es)
PT (1) PT2970263T (es)
RS (1) RS57569B1 (es)
RU (1) RU2660424C2 (es)
SG (2) SG11201507360XA (es)
SI (1) SI2970263T1 (es)
TW (2) TWI735759B (es)
UA (1) UA118667C2 (es)
UY (3) UY39847A (es)
WO (1) WO2014165044A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104370905B (zh) * 2014-10-22 2016-06-01 南京友杰医药科技有限公司 Bcl-2抑制剂ABT-199的合成
EP3426655A1 (en) 2016-03-10 2019-01-16 Assia Chemical Industries Ltd. Solid state forms of venetoclax and processes for preparation of venetoclax
CN107089981A (zh) * 2017-04-24 2017-08-25 杭州科耀医药科技有限公司 一种BCL‑2抑制剂Venetoclax的合成方法
IL272762B2 (en) 2017-08-23 2024-03-01 Newave Pharmaceutical Inc Compressed heterocyclics as BCL-2 inhibitors for the treatment of neoplastic diseases
CN108037196B (zh) * 2017-11-23 2020-06-23 中山奕安泰医药科技有限公司 一种3-硝基-4-[[(四氢-2h-吡喃-4-基)甲基]氨基]苯磺酰胺的检测方法
BR112020014169A2 (pt) 2018-01-10 2020-12-08 Recurium Ip Holdings, Llc Compostos de benzamida
WO2020003272A1 (en) 2018-06-29 2020-01-02 Fresenius Kabi Oncology Ltd. An improved process for the preparation of venetoclax
CN108997333A (zh) * 2018-07-04 2018-12-14 江苏中邦制药有限公司 一种b细胞淋巴瘤因子-2抑制剂abt-199的制备方法
WO2020023435A1 (en) 2018-07-24 2020-01-30 Albany Molecular Research, Inc. Venetoclax basic salts and processes for the purification of venetoclax
US11903950B2 (en) 2018-08-22 2024-02-20 Newave Pharmaceutical Inc. BCL-2 inhibitors
WO2020049599A1 (en) * 2018-09-07 2020-03-12 Msn Laboratories Private Limited, R&D Center Process for the preparation of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1- yl]methyl}piperazin-1-yl)-n-({3-nitro-4-[(tetrahydro-2h-pyran-4-ylmethyl)amino] phenyl}sulfonyl)-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide)
CN112079795B (zh) * 2020-09-16 2022-12-09 广东莱佛士制药技术有限公司 一种维奈托克中间体及其类似物的合成方法
IT202100025976A1 (it) 2021-10-06 2023-04-06 Univ Degli Studi Di Perugia Combinazione di principi attivi per il trattamento della leucemia acuta mieloide (LAM) con mutazione della nucleofosmina (NPM1)
CN114163369A (zh) * 2021-12-17 2022-03-11 武汉工程大学 一种含硫/氧酯基芳烃化合物的制备方法
CN116496239A (zh) * 2022-12-14 2023-07-28 南京哈柏医药科技有限公司 一种维奈托克关键中间体及原料药的合成方法
EP4421075A1 (en) 2023-02-27 2024-08-28 KRKA, d.d., Novo mesto Process for the preparation of venetoclax and intermediates used therein

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB585940A (en) 1944-09-01 1947-02-28 Kodak Ltd Bicyclic compounds containing the diphenylamine grouping, process of making them and their use in the colouration of textile materials other than cellulose
US3813443A (en) 1970-11-18 1974-05-28 Us Agriculture Boll weevil sex attractant
SI1553097T1 (sl) 1999-02-10 2010-12-31 Astrazeneca Ab Kinazolinski derivati kot inhibitorji angiogeneze in intermediati za to
RU2448099C2 (ru) 2004-12-02 2012-04-20 Дайити Санкё Компани, Лимитед 7-членные циклические соединения, способы их получения и их фармацевтическое применение
CN1827582A (zh) * 2006-04-18 2006-09-06 江苏中丹化工集团公司 6-[3-(1-金刚烷基)-4-甲氧基苯基]-2-萘甲酸甲酯的制备方法
BRPI0810719A8 (pt) * 2007-04-30 2016-03-08 Abbott Lab Inibidores da enzima diacilglicerol o-acetiltansferase tipo 1
EP2323989A4 (en) 2008-03-20 2011-06-22 Abbott Lab METHODS FOR PREPARING AGENTS FOR THE CENTRAL NERVOUS SYSTEM THAT ARE TRPV1 ANTAGONISTS
US20100160322A1 (en) * 2008-12-04 2010-06-24 Abbott Laboratories Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
UA108193C2 (uk) * 2008-12-04 2015-04-10 Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань
NZ593593A (en) * 2009-01-19 2013-11-29 Abbvie Inc Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
US8546399B2 (en) 2009-05-26 2013-10-01 Abbvie Inc. Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
CN101990094B (zh) 2009-08-05 2012-11-21 炬力集成电路设计有限公司 一种码流分析方法和装置
CN102030651A (zh) * 2009-09-28 2011-04-27 莱阳市盛华科技有限公司 2-氟-4-溴联苯基甲酸乙酯的合成方法
TWI520960B (zh) * 2010-05-26 2016-02-11 艾伯維有限公司 用於治療癌症及免疫及自體免疫疾病之細胞凋亡誘導劑
DE102010027213A1 (de) * 2010-07-15 2012-01-19 Continental Automotive Gmbh Verfahren und Steuergerät zum Steuern einer Brennkraftmaschine
JP6068352B2 (ja) 2010-10-29 2017-01-25 アッヴィ・インコーポレイテッド アポトーシス誘発剤を含む固体分散体
UA113500C2 (xx) 2010-10-29 2017-02-10 Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб
PT2643322T (pt) 2010-11-23 2017-11-13 Abbvie Inc Sais e formas cristalinas de um agente indutor de apoptose
SG10201509631SA (en) 2010-11-23 2015-12-30 Abbvie Bahamas Ltd Methods of treatment using selective bcl-2 inhibitors

Also Published As

Publication number Publication date
RU2660424C2 (ru) 2018-07-06
SG10201701680YA (en) 2017-04-27
TWI631121B (zh) 2018-08-01
PL2970263T3 (pl) 2018-10-31
AU2018203977B2 (en) 2019-07-11
CA2903797C (en) 2022-06-21
RS57569B1 (sr) 2018-10-31
CA3183040A1 (en) 2014-10-09
HK1216644A1 (zh) 2016-11-25
TW201825491A (zh) 2018-07-16
TW201522334A (zh) 2015-06-16
CN105164128A (zh) 2015-12-16
HK1251231A1 (zh) 2019-01-25
RU2015143637A (ru) 2017-04-19
NZ711315A (en) 2020-10-30
DK2970263T3 (en) 2018-08-13
IL257109B (en) 2019-01-31
NZ751139A (en) 2020-10-30
HUE039046T2 (hu) 2018-12-28
PH12015501960B1 (en) 2016-01-11
CA2903797A1 (en) 2014-10-09
JP6357220B2 (ja) 2018-07-11
JP2016514137A (ja) 2016-05-19
EP2970263B1 (en) 2018-05-09
JP2018138571A (ja) 2018-09-06
CA3090936A1 (en) 2014-10-09
JP6578037B2 (ja) 2019-09-18
AU2014248742B2 (en) 2018-04-05
ES2683378T3 (es) 2018-09-26
CN111960944A (zh) 2020-11-20
PT2970263T (pt) 2018-10-03
CN105164128B (zh) 2017-12-12
LT2970263T (lt) 2018-08-27
SG11201507360XA (en) 2015-10-29
IL240779A0 (en) 2015-10-29
BR122021025053B1 (pt) 2022-09-06
CN107721851B (zh) 2021-06-25
KR20150128994A (ko) 2015-11-18
MY192466A (en) 2022-08-22
EP3569588A1 (en) 2019-11-20
PH12015501960A1 (en) 2016-01-11
AU2018203977A1 (en) 2018-06-21
CL2015002548A1 (es) 2016-03-18
EP2970263A1 (en) 2016-01-20
WO2014165044A1 (en) 2014-10-09
SI2970263T1 (sl) 2018-09-28
PH12018501094A1 (en) 2019-11-25
HRP20181273T1 (hr) 2018-11-16
IL240779B (en) 2018-04-30
UY39847A (es) 2022-09-30
CA3090936C (en) 2023-02-07
EP3293185A1 (en) 2018-03-14
BR122021025062B1 (pt) 2022-04-19
UA118667C2 (uk) 2019-02-25
PE20151809A1 (es) 2015-12-25
MX365343B (es) 2019-05-30
BR112015021540A2 (pt) 2017-07-18
CR20150495A (es) 2015-12-03
TWI735759B (zh) 2021-08-11
CY1120576T1 (el) 2019-07-10
CN107721851A (zh) 2018-02-23
AU2014248742A1 (en) 2015-09-10
PE20191685A1 (es) 2019-11-19
EP3954687A1 (en) 2022-02-16
KR102230339B1 (ko) 2021-03-23
MX2015012000A (es) 2015-12-01
BR112015021540B1 (pt) 2022-04-19
UY39848A (es) 2022-09-30
EP4019491A1 (en) 2022-06-29

Similar Documents

Publication Publication Date Title
UY35394A (es) Procesos para la preparación de un agente inductor de la apoptosis
JOP20200192A1 (ar) أجسام مضادة لـ tigit
EA201792613A1 (ru) Модуляторы cot и способы их применения
PH12016501763A1 (en) Multispecific antibodies
EA202092435A2 (ru) Моноклональные антитела против bcma
MX2017002538A (es) Absorbedor para unión de metales y la producción del mismo.
DK3142785T3 (da) Fremgangsmåde til fremstilling af alkenoler og anvendelse deraf til fremstilling af 1,3-butadien
EA201792612A1 (ru) 6-аминохинолин-3-карбонитрилы в качестве модуляторов cot
CL2015000926A1 (es) Proceso para la elaboración de compuestos para el tratamiento del cancer derivados de azetidin-1-il-metanona y compuestos intermediarios.
EA201790312A1 (ru) Комбинации лекарственных средств для лечения множественной миеломы
EA201790982A1 (ru) Синтез копанлисиба и его дигидрохлорида
IN2013MU00848A (es)
CL2014002389A1 (es) Proceso y aparato integrado para la producción de ozono y oxigeno.
IN2013MU01113A (es)
MX2016005223A (es) Tinturas dispersas, su preparacion y su uso.
CL2016001505A1 (es) Proceso para la producción de gas de síntesis de amoníaco.
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
FR2987047B1 (fr) Utilisations des derives de carbazolophenones pour le traitement du cancer.
NZ743656A (en) Methods of treating a tauopathy
TH1501007377B (th) กระบวนการสำหรับการผลิตอีพอกซี-โมโนเมอร์ และ อีพอกไซด์
UA96859U (uk) Застосування рослинного збору "дента-фіт" для лікування запальних захворювань пародонта
TH1601001035B (th) การออกแบบตารางแถบความถี่สำหรับขั้นตอนวิธีการคืนรูปความถี่ระดับสูง
TH1401007612B (th) วิธีการผลิตและชุดเครื่องสำหรับผลิตของตัวชิ้นส่วนที่ขึ้นรูปด้วยการกด
TH1501007355B (th) เครื่องและวิธีสำหรับการบำบัดน้ำเสียจากการผลิตแอลกอฮอล์
TH1501006845A (th) สารประกอบ เตตระแอริล บอเรตใหม่ และวิธีการสำหรับการผลิตสารประกอบดังกล่าว

Legal Events

Date Code Title Description
110 Patent granted

Effective date: 20221025